(Q36968246)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

MF59-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

David González Vidal

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

659-665

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

The impact of influenza epidemics on hospitalizations.

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Influenza-associated hospitalizations in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Impact of respiratory virus infections on persons with chronic underlying conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

A new MF59-adjuvanted influenza vaccine enhances the immune response in the elderly with chronic diseases: results from an immunogenicity meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Antibody responses and HIV-1 viral load in HIV-1-seropositive subjects immunised with either the MF59-adjuvanted influenza vaccine or a conventional non-adjuvanted subunit vaccine during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Response of influenza vaccines against heterovariant influenza virus strains in adults with chronic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Evidence of increased clinical protection of an MF59-adjuvant influenza vaccine compared to a non-adjuvant vaccine among elderly residents of long-term care facilities in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Object-oriented influence diagram for cost-effectiveness analysis of influenza vaccination in the Italian elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Influenza vaccination: policy versus evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Equipoise and the ethics of clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.659

21 January 2018

Identifiers

DOI

10.1586/14760584.6.5.659

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17931147%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference